Attached files
file | filename |
---|---|
10-K/A - FORM 10-K (AMENDMENT NO. 1) - EyePoint Pharmaceuticals, Inc. | d273854d10ka.htm |
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - EyePoint Pharmaceuticals, Inc. | d273854dex311.htm |
EX-10.13 - AMENDED AND RESTATED COLLABORATIVE RESEARCH AND LICENSE AGREEMENT - EyePoint Pharmaceuticals, Inc. | d273854dex1013.htm |
Exhibit 31.2
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
CERTIFICATIONS
I, Leonard S. Ross, certify that:
1. | I have reviewed this Annual Report on Form 10-K/A (Amendment No. 1) of PSIVIDA CORP.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
Date: December 27, 2011
/S/ LEONARD S. ROSS | ||
Name: | Leonard S. Ross | |
Title: | Vice President, Finance (Principal Financial and Accounting Officer) |